Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 720 of 6351
-
Ketamine infusions could help curb meth addiction, new trial hopes
Disease control OngoingThis study aims to determine whether treatment response with IV ketamine is superior to treatment response with IV midazolam in adults with moderate to severe MUD. The study design is a 12-week randomized, double-blind, controlled trial comparing intravenous (IV) ketamine agains…
Phase 2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Promising new combo aims to tame rare lymphoma with less radiation
Disease control OngoingInvestigate the efficacy and safety of Orelabrutinib followed by response-adapted ultra-low dose 4Gy radiation in the treatment of local-stage MALT lymphoma
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New drug cocktail aims to outsmart Treatment-Resistant melanoma
Disease control Recruiting nowThe purpose of this study is to test whether the combination of fianlimab, cemiplimab, and ipilimumab is a safe and effective treatment that causes few or mild side effects for locally advanced or metastatic, unresectable, refractory melanoma.
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Blood test software could spot pancreatic cancer early in High-Risk groups
Diagnosis Recruiting nowSoftware "Lipidica" is intended to be used for processing data generated by the in-house in vitro diagnostic medical device for lipidomic testing for the purpose of screening Pancreatic cancer (PaC) in the population at high risk of this cancer due to familial risk, selected gene…
Sponsor: Lipidica, a.s. • Aim: Diagnosis
Last updated Jun 27, 2026 12:25 UTC
-
New combo therapy aims to slow advanced breast cancer
Disease control Recruiting nowPhase II clinical trial of PD-L1 in combination with vinorelbine + cyclophosphamide + capecitabine (VEX) metronomic chemotherapy with or without radiotherapy for advanced triple-negative breast cancer.
Phase 2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Hope for ME/CFS and long COVID: new drug combo trial launches
Disease control Recruiting nowThe LIFT will be conducted at Brigham and Women's Hospital (BWH) of Harvard Medical School, focusing on the effect of Pyridostigmine (Mestinon) and Low-Dose Naltrexone (LDN) in subjects aged 18-70 meeting the Canadian consensus criteria (CCC) for Myalgic Encephalomyelitis/Chronic…
Phase 2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New pill could stop Period-Linked migraines before they start
Disease control OngoingA migraine is a moderate to severe headache typically on one side of the head. A migraine attack is a headache that may be accompanied by throbbing, nausea, vomiting, sensitivity to light and sound, or other symptoms. Menstrual migraine (MM) is defined as migraine attacks that oc…
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New ultrasound-guided treatment could save lives from deadly lung clots
Disease control Recruiting nowPulmonary embolism (PE) is a life-threatening condition and a leading cause of cardiovascular mortality. While systemic thrombolysis is the standard treatment for high-risk PE, its bleeding risk limits use in some patients, highlighting the need for alternative reperfusion strate…
Sponsor: National Medical Research Center for Cardiology, Ministry of Health of Russian Federation • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New prostate cancer trial aims to cut fatigue with personalized drug plan
Disease control Recruiting now1. Personalize treatment for prostate cancer based on how aggressive the disease is and 2. Learn if apalutamide-based treatment can help to reduce fatigue and other side effects of treatment in participants who are being treated with radiation therapy for prostate cancer, as comp…
Phase 3 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Can fasting and exercise beat cancer fatigue?
Symptom relief Recruiting nowThe purpose of this study is to test whether four different supportive care programs can reduce fatigue in women with advanced or metastatic breast cancer who are receiving a medication called a CDK4/6 inhibitor (palbociclib, ribociclib, or abemaciclib) alongwith endocrine therap…
Sponsor: University of Miami • Aim: Symptom relief
Last updated Aug 28, 2026 00:00 UTC
-
New drug combo aims to tackle tough lymphoma
Disease control Recruiting nowThis phase II trial tests how well mosunetuzumab and polatuzumab vedotin works in treating patients with grade 1-3a follicular lymphoma that has come back after a period of improvement (relapsed) or that has not responded to previous treatment (refractory). Mosunetuzumab is a mon…
Phase 2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
AI hunts for early clues to Parkinson's and Alzheimer's progression
Knowledge-focused Recruiting nowMARKERS-NDD is a prospective, observational, longitudinal study, which aims to collect data from patients affected by neurodegenerative diseases (NDD) followed longitudinally for routine examinations performed as part of normal clinical practice. Data collected from clinical eval…
Sponsor: Casa di Cura San Raffaele Cassino • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
New hope for hairy cell leukemia: Chemo-Free combo tested
Disease control Recruiting nowThe researchers are doing this study to compare the safety of vemurafenib in combination with obinutuzumab to the standard of approach of cladribine in combination with rituximab. The researchers will look at which treatment causes fewer or milder side effects. Researchers think …
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Sep 10, 2026 01:00 UTC
-
New mRNA vaccines aim to outsmart evolving COVID variants
Vaccine Recruiting nowThe purpose of this study is to investigate the immunogenicity and safety of mRNA COVID-19 variant-containing vaccine formulations against the vaccine-matched variants and newly emerged variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Phase 4 • Sponsor: ModernaTX, Inc. • Aim: Vaccine
Last updated Jun 27, 2026 12:01 UTC
-
Cheaper keytruda copy? new trial tests biosimilar for lung cancer
Disease control OngoingThe primary objective of this trial is to demonstrate pharmacokinetic (PK) similarity of ABP 234 compared with the pembrolizumab reference product (Keytruda®).
Phase 3 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New hope for advanced melanoma: experimental combo faces off against approved treatment
Disease control Recruiting nowThis study is researching an experimental drug called fianlimab (also known as REGN3767), combined with another medication called cemiplimab (also known as REGN2810), called "study drugs". The study is focused on patients with a type of skin cancer known as melanoma. The aim of t…
Phase 3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Heart attack prevention hope for rare cholesterol disorder
Disease control OngoingThis observational, multicenter, retrospective and prospective study aims to evaluate the effect of lomitapide treatment on Major Adverse Cardiovascular Events (MACE) in patients with Homozygous Familial Hypercholesterolemia (HoFH). HoFH is a rare genetic disorder characterized …
Sponsor: Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi) • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Could stem cells restore erectile function? new trial tests the idea
Disease control OngoingErectile dysfunction (ED) is a common condition characterized by the inability to achieve or maintain an erection sufficient for satisfactory sexual activity. It can significantly affect physical health, emotional well-being, and quality of life for both patients and their partne…
Phase 2 • Sponsor: National Scientific Medical Center, Kazakhstan • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Training the heart to calm the brain: a new hope for functional neurological disorders?
Symptom relief OngoingEvaluation of the clinical effects of the Heart Rate Variability biofeedback training with patients suffering from Functional neurological Disorders compared with placebo.
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Could a simple mineral cut opioid use in Kids' surgery?
Symptom relief Recruiting nowMagnesium sulfate is one of the most commonly used co-analgetics. Its antinociceptive effect is related to antagonizing NMDA (N-methyl-D-aspartate) receptors of the nervous system, has an anti-inflammatory effect by reducing the concentration of IL-6 (interleukin 6) and tumor nec…
Phase 4 • Sponsor: Medical University of Warsaw • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC